Dark Forest Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,235
Closed -$753K 1199
2024
Q4
$753K Sell
4,235
-2,702
-39% -$497K 0.11% 261
2024
Q3
$1.37M Buy
+6,937
New +$1.29M 0.18% 122
2023
Q3
Sell
-1,762
Closed -$237K 1065
2023
Q2
$237K Buy
+1,762
New +$258K 0.02% 894
2022
Q3
Sell
-1
Closed 1090
2022
Q2
$0 Sell
1
-63
-98% -$9.63K ﹤0.01% 855
2022
Q1
$10K Buy
+64
New +$9.3K ﹤0.01% 989
2021
Q4
Sell
-1,246
Closed -$134K 1380
2021
Q3
$134K Sell
1,246
-3,632
-74% -$415K 0.05% 312
2021
Q2
$549K Buy
+4,878
New +$549K 0.24% 27

Other funds holding ABBV

Dark Forest Capital Management's ABBV Position: Q1 2025 in Review

Dark Forest Capital Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 4,235 shares — an estimated $753K sold.

Dark Forest Capital Management first reported a position in ABBV in Q2 2021 and held it in 7 quarters. The position peaked at $1.37M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Dark Forest Capital Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 4,235 AbbVie shares in Q1 2025, an estimated $753K.
  • Dark Forest Capital Management first reported a position in AbbVie in Q2 2021 and held it in 7 quarters.
  • Dark Forest Capital Management's AbbVie position peaked at $1.37M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Dark Forest Capital Management's 13F filing for Q1 2025, filed 15 May 2025.